- $2.06bn
- $1.78bn
- $631.10m
FIGS down after Raymond James downgrades stock to 'market perform'
Brief: FIGS Q1 revenue USD 120.2 million
Figs Inc reports results for the quarter ended in March - Earnings Summary
U.S. STOCKS ON THE MOVE-CVRx, Tesla, So-Young International
U.S. RESEARCH ROUNDUP-Chart Industries, Nvidia, Seagen
U.S. STOCKS ON THE MOVE-Knight-Swift, BioNTech, US regional banks
U.S. STOCKS ON THE MOVE-Nvidia, U.S. oil companies, Tesla
U.S. STOCKS ON THE MOVE-First Republic, U.S. banks, Meta Platforms
Short-term costs likely to weigh on Figs' profitability- Oppenheimer
U.S. STOCKS ON THE MOVE-First Solar, Iveric Bio, Salesforce
Figs hits 2-month low on lower Q4 profit, weaker revenue forecast
Figs Inc reports results for the quarter ended in December - Earnings Summary
Brief: Figs Releases Fourth Quarter And Full Year 2022 Financial Results
Figs Inc expected to post earnings of 1 cent a share - Earnings Preview
Brief: FIGS Says Strategic Partners and Co have settled all litigation brought by SPI against FIGS
Brief: Statement By Careismatic Brands, Inc. Regarding Settlement Of Litigation With Figs, Inc
U.S. RESEARCH ROUNDUP-Evoqua Water Technologies, Taysha Gene Therapies, Veradigm
U.S. RESEARCH ROUNDUP-Evoqua Water Technologies, Taysha Gene Therapies, Veradigm
NYSE ORDER IMBALANCE 72646.0 SHARES ON SELL SIDE